The comorbidity of alcohol dependence and affective disorders: treatment implications (Q44689212)

5 December 2017

1 reference

title

The comorbidity of alcohol dependence and affective disorders: treatment implications (English)

1 reference

5 December 2017

1 reference

1 reference

1

Lynskey MT

1 reference

5 December 2017

publication date

1 November 1998

1 reference

Drug and Alcohol Dependence

5 December 2017

published in

1 reference

5 December 2017

volume

52

1 reference

5 December 2017

issue

3

1 reference

5 December 2017

page(s)

201-209

1 reference

Patient factors related to early attrition from an outpatient cocaine research clinic: a preliminary report.

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900095-7

7 January 2021

The prevalence of specific psychiatric disorders in Puerto Rico.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900095-7

7 January 2021

Comorbidity in Child Psychopathology: Concepts, Issues and Research Strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900095-7

7 January 2021

Preferences for ethanol and diazepam in anxious individuals: an evaluation of the self-medication hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900095-7

7 January 2021

Fluoxetine in depressed alcoholics. A double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900095-7

7 January 2021

Prevalence and comorbidity of DSM-III-R diagnoses in a birth cohort of 15 year olds

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900095-7

7 January 2021

Prediction of resumption of drinking in posttreatment alcoholics

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900095-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900095-7

1 reference

7 January 2021

Toward an alcohol treatment model: a comparison of treated and untreated respondents with DSM-IV alcohol use disorders in the general population

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900095-7

7 January 2021

Comorbidity between DSM-IV alcohol use disorders and major depression: results of a national survey

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900095-7

7 January 2021

Screening for major depression among alcoholics: an application of receiver operating characteristic analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900095-7

7 January 2021

What have population surveys revealed about substance use disorders and their co-morbidity with other mental disorders?

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900095-7

7 January 2021

Twin studies of psychiatric illness. Current status and future directions

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900095-7

7 January 2021

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900095-7

7 January 2021

Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900095-7

7 January 2021

Comorbid psychiatric diagnosis predicts three-year outcomes in alcoholics: a posttreatment natural history study

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900095-7

7 January 2021

Imipramine treatment of alcoholics with primary depression: A placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900095-7

7 January 2021

Fluoxetine: a spectrum of clinical applications and postulates of underlying mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900095-7

7 January 2021

Prognostic effect of the variable course of alcoholism on the 10-year course of depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900095-7

7 January 2021

Zimelidine-induced variations in alcohol intake by nondepressed heavy drinkers

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900095-7

7 January 2021

The serotonin uptake inhibitor citalopram attenuates ethanol intake

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900095-7

7 January 2021

Fluoxetine differentially alters alcohol intake and other consummatory behaviors in problem drinkers.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900095-7

7 January 2021

Psychiatric symptoms in alcoholics attending outpatient treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900095-7

7 January 2021

Co‐Morbidity of Lifetime Psychiatric Disorder Among Male Alcoholic Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900095-7

7 January 2021

Outcomes of Co‐Morbid Alcoholic Men: A 1‐Year Follow‐Up

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900095-7

7 January 2021

DSM-III-R alcohol abuse and dependence and psychiatric comorbidity in Ontario: results from the Mental Health Supplement to the Ontario Health Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900095-7

7 January 2021

Sex differences in the prevalence of psychiatric disorders in patients with alcohol and drug problems.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900095-7

7 January 2021

Depression among alcoholics. Relationship to clinical and cerebrospinal fluid variables

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900095-7

7 January 2021

Comparison of induced and independent major depressive disorders in 2,945 alcoholics

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900095-7

7 January 2021

The life-time rates of three major mood disorders and four major anxiety disorders in alcoholics and controls

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900095-7

7 January 2021

Does depression predict relapse in the 6 months following treatment for men with alcohol dependence?

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900095-7

7 January 2021

Genetic and environmental contributions to the correlation between alcohol consumption and symptoms of anxiety and depression. Results from a bivariate analysis of Norwegian twin data

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900095-7

7 January 2021

Christchurch Psychiatric Epidemiology Study, Part I: Methodology and lifetime prevalence for specific psychiatric disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900095-7

7 January 2021

Cognitive-behavioral treatment for depression in alcoholism

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900095-7

7 January 2021

Comorbidity and treatment planning: summary and future directions

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900095-7

7 January 2021

Recent developments in the pharmacotherapy of mood disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900095-7

7 January 2021

10.1016/S0376-8716(98)00095-7

Identifiers

DOI

1 reference

5 December 2017

1 reference